A federal health advisory panel has recommended that all U.S. adults younger than age 60 get vaccinated against hepatitis B.
Under the new policy, tens of millions of adults between the ages of 30 and 59 could get vaccines against the potentially chronic liver disease. Hepatitis B vaccinations became the standard for children in 1991, meaning most adults younger than 30 already have received them.